Apollon Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
4,014
+1,183
+42% +$439K 0.02% 569
2026
Q1
$829K Sell
2,831
-584
-17% -$192K 0.01% 669
2025
Q4
$1.2M Sell
3,415
-261
-7% -$88.2K 0.02% 516
2025
Q3
$1.19M Buy
3,676
+255
+7% +$79.3K 0.02% 520
2025
Q2
$1.33M Buy
3,421
+806
+31% +$324K 0.03% 466
2025
Q1
$1.14M Sell
2,615
-100
-4% -$40.1K 0.03% 474
2024
Q4
$1M Sell
2,715
-759
-22% -$318K 0.02% 514
2024
Q3
$1.81M Sell
3,474
-311
-8% -$166K 0.05% 332
2024
Q2
$2.05M Buy
3,785
+553
+17% +$292K 0.06% 284
2024
Q1
$1.68M Buy
3,232
+104
+3% +$51.7K 0.05% 330
2023
Q4
$1.48M Buy
3,128
+1,206
+63% +$558K 0.05% 336
2023
Q3
$837K Sell
1,922
-1,068
-36% -$484K 0.04% 407
2023
Q2
$1.33M Sell
2,990
-315
-10% -$145K 0.06% 311
2023
Q1
$1.52M Sell
3,305
-10
-0.3% -$4.76K 0.09% 225
2022
Q4
$1.7M Buy
3,315
+787
+31% +$400K 0.12% 179
2022
Q3
$1.15M Buy
2,528
+1,065
+73% +$510K 0.09% 220
2022
Q2
$706K Buy
1,463
+426
+41% +$211K 0.06% 345
2022
Q1
$509K Buy
1,037
+249
+32% +$114K 0.04% 455
2021
Q4
$365K Buy
+788
New +$332K 0.03% 535
2021
Q2
Sell
-2,350
Closed -$844K 367
2021
Q1
$844K Buy
+2,350
New +$756K 0.16% 125
2020
Q3
Sell
-40
Closed -$11K 306
2020
Q2
$11K Buy
+40
New +$10.7K 0.01% 479

Other funds holding ELV

Apollon Wealth Management's ELV Position: Q2 2026 in Review

Apollon Wealth Management increased its Elevance Health (ELV) stake by 42% in Q2 2026, buying an estimated $439K and bringing the position to 4,014 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #569.

Apollon Wealth Management first reported a position in ELV in Q2 2020 and has held it in 21 quarters since. The position peaked at $2.05M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Apollon Wealth Management held 4,014 shares of Elevance Health worth $1.55M as of Q2 2026.
  • Apollon Wealth Management bought 1,183 Elevance Health shares in Q2 2026, an estimated $439K.
  • Elevance Health made up 0.02% of Apollon Wealth Management's portfolio in Q2 2026, its #569 holding.
  • Apollon Wealth Management first reported a position in Elevance Health in Q2 2020 and has held it in 21 quarters since.
  • Apollon Wealth Management's Elevance Health position peaked at $2.05M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.